Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan for Treatment of COVID-19
NCT04355936Phase 4Completed
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan in coronavirus disease 2019 (COVID-19), sponsored by Laboratorio Elea Phoenix S.A.. Started May 2020; status: completed.
02
Drugs
telmisartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04355936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355936.